Diclofenac Sodium/Misoprostol

双氯芬酸钠/米索前列醇

Report date: 2022/03/23 10:15:34

Base Information

Drug NameDiclofenac Sodium/Misoprostol
Drug Alias Name米索前列醇/双氯芬酸钠misoprostol and diclofenac sodiumMisoprostol/diclofenac sodiumdiclofenac sodium and misoprostolArthrotec +[6] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsProstanoid EP2 receptor agonists
TargetsProstanoid EP2 receptorCyclooxygenases
Therapy Area/IndicationsOsteoarthritisArthritis, Rheumatoid
Global Approved IndicationsOsteoarthritisArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1997/12/24
Country/TerritoryUnited States
CombinationsYes Diclofenac SodiumMisoprostol
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesHui Zhi Pharmaceutical (Dalian) Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritisArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeM01AB55
Related LinksN/A